Webinar: Selecting and successfully integrating cognitive testing into clinical trials
On May 9, we presented the webinar: Selecting and successfully integrating cognitive testing into clinical trials
During this webinar, hosted by Dr. Lieza Exalto, speaker Dr. John Harrison discussed:
- Cognitive domains – which ones should we focus on?
- Are current ‘gold standard’ cognitive outcome measures fit for purpose?
- Is the MMSE the best metric for selecting Alzheimer’s trial study participants?
- Statistically significant, but is it clinically relevant?
You can watch the replay below:
Related webinars
Webinar – Time to event trial designs in ALS: How useful are they?
On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...
Webinar – Clinical consequences of the New MASLD Nomenclature
On the 27th of June, we organized the webinar: 'Clinical Consequences of the New MASLD Nomenclature' with guest speaker Prof. Maja Thiele.During this webinar, our speaker and hosts dived into the following topics:Is the MASLD nomeclature...
Webinar: Plasma biomarkers for diagnosis and monitoring of neurodegenerative disorders
On October 15, at 16.00 CEST, we presented the webinar:Plasma biomarkers for diagnosis and monitoring of neurodegenerative disordersTopics that are discussed:Plasma biomarkers, such as Amyloid, pTau and NfL. Treatment effect in ne...